MA02.03 ASTRIS: A Real World Treatment Study of Osimertinib in Patients with EGFR T790M-Positive NSCLC

著录项

• 来源
  《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer 》 |2018年第10期| 共2页
• 作者

  Y. Wu; B.C. Cho; Q. Zhou; G. Chang; L. Jiang; G. Metro; C. Martin; G. De Castro; J. Vansteenkiste; D. Vicente; A. Milner; J. Rigas; Y. Chen; M. Provencio;

  展开▼
• 作者单位

  Guangdong Lung Cancer Institute Guangdong General Hospital and Guangdong Academy of Medical;

  Yonsei Cancer Center Yonsei University College of Medicine;

  Guangdong Lung Cancer Institute Guangdong General Hospital and Guangdong Academy of Medical;

  Department of Internal Medicine Division of Chest Medicine at Taichung Veterans General Hospital;

  Shanghai Chest Hospital Shanghai Jiao Tong University;

  Santa Maria Della Misericordia Hospital;

  Department of Clinical Oncology Instituto Alexander Fleming;

  Instituto Do Cancer Do Estado de S?o Paulo;

  University Hospital KU Leuven;

  H.U.V. Macarena;

  Biometrics and Information Sciences;

  Gma Oncology Ta Astrazeneca;

  Department of Chest Medicine Taipei Veterans General Hospital;

  Medical Oncology Hospital Puerta de Hierro;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学 ;
• 关键词